Common Contracts

4 similar Registration Rights Agreement contracts by CNS Response, Inc., NXT Nutritionals Holdings, Inc., WaferGen Bio-Systems, Inc.

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • November 29th, 2011 • NXT Nutritionals Holdings, Inc. • Sugar & confectionery products

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and Purchaser (the “Purchase Agreement”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • November 8th, 2010 • CNS Response, Inc. • Services-misc health & allied services, nec

This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 26, 2009 among CNS Response, Inc., a Delaware corporation (the “Company”), and the Maxim Group, LLC (“Maxim”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • July 6th, 2010 • CNS Response, Inc. • Services-misc health & allied services, nec

This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 26, 2009 among CNS Response, Inc., a Delaware corporation (the “Company”), and the Maxim Group, LLC (“Maxim”).

FORM OF REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • June 5th, 2007 • WaferGen Bio-Systems, Inc. • Retail-eating & drinking places • New York

This Agreement is made pursuant to and in connection with (i) the Subscription Agreements between the Company and each Purchaser dated as of the date hereof (collectively, the “Purchase Agreements”), (ii) the Private Placement Memorandum dated April 16, 2007 relating to the offering of units of the Company’s securities, consisting of Common Stock of the Company (the “Shares” as defined below) and warrants to purchase Common Stock of the Company (the “Warrants”), pursuant to which the Purchasers purchased the Registrable Securities (the “Memorandum”) and (iii) the proposed merger (the “Merger”) of a wholly-owned subsidiary of the Company with and into WaferGen, Inc., a Delaware corporation, with WaferGen, Inc. remaining as the surviving entity and a wholly-owned subsidiary of the Company.